Texas Oncology is a clinical research site located in McAllen, Texas, United States 78503.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Texas Oncology has participated in 7 clinical trials with 2 currently active.
Therapeutic areas: Advanced, Metastatic Breast Cancer, Low Grade Ovarian Serous Adenocarcinoma, Ovarian Cancer.
Sponsors: Novartis Pharmaceuticals, Verastem, Inc., Pfizer.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology has 7 clinical trials on record, with 2 currently active. Their work covers Advanced, Metastatic Breast Cancer, Low Grade Ovarian Serous Adenocarcinoma, Ovarian Cancer.
Yes — Texas Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.